Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc. IR Overview
  • Investors
  • Presentations
  • Analyst Coverage
  • News / Events
    • Press Releases
    • Events
  • Company Information
    • Profile
    • IR Contacts
    • FAQ
  • Financial Information
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to www.corbuspharma.com

Press Releases

News / Events

News / Events

  • Press Releases
  • Events
Oct 16, 2023 • 8:00 am EDT
Corbus Pharmaceuticals Presents the First Pre-Clinical Characterization of its Next Generation Nectin-4 ADC CRB-701
Oct 3, 2023 • 8:00 am EDT
Corbus Pharmaceuticals to Host Virtual ‘Meet the Expert’ Series (Session 2) on CRB-701 on October 10, 2023
Sep 27, 2023 • 9:05 am EDT
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
Sep 19, 2023 • 8:00 am EDT
Corbus Pharmaceuticals to Present Pre-Clinical Data Characterizing its CRB-701 Nectin-4 ADC at the at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Aug 8, 2023 • 8:00 am EDT
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jul 31, 2023 • 8:00 am EDT
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
Jun 26, 2023 • 8:00 am EDT
Corbus Pharmaceuticals Set to Join Russell Microcap® Index
May 31, 2023 • 8:00 am EDT
Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference
May 9, 2023 • 8:00 am EDT
Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 1, 2023 • 8:00 am EDT
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Corbus Pharmaceuticals Holdings, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement